Carbapenem-resistant Enterobacteriaceae (CRE)
The term CRE refers to carbapenem-resistant and carbapenemase-producing Enterobacteriaceae. Currently, the most common type of carbapenemase in the United States is the Klebsiella pneumoniae carbapenemase (KPC). In 2010, carbapenemases known as metallo-beta-lactamases (MBL) were first detected in the U.S.: New Delhi MBL (known as NDM-1) and Verona-Integron encoded MBL (known as VIM).
- About CRE
CRE facts including: what CRE are, how CRE are spread, and how to prevent CRE.
CRE Information For Health Professionals:
- CRE Resistance Mechanisms
Information for health care personnel about resistance mechanisms responsible for CRE.
- Surveillance Case Definiton and Reporting
CRE surveillance definition and reporting to MDH.
- Laboratory Testing and Protocols
Laboratory testing protocols for CRE and isolate submission to MDH.
- Recommendations for the Management of CRE in Acute and Long-term Acute Care Hospitals
MDH recommendations for the prevention and control of carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae in acute and long-term acute care facilities.
- Other Guidelines and Resources
Guidelines, publications, and resources to prevent CRE transmission in health care facilities.
Spotlight
Hand Hygiene
Information about washing/cleaning your hands.
Antimicrobial Susceptibilities of Selected Pathogens (MDH Antibiogram)
If you have questions or comments about this page, use our IDEPC Comment Form or call 651-201-5414 (TTY: 651-201-5797) for the MDH Infectious Disease Epidemiology, Prevention and Control Division.
